Market Tracker

05/01 6:02pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

35.67
Delayed Data
As of May 01
 +1.50 / +4.39%
Today’s Change
17.15
Today|||52-Week Range
46.48
+12.35%
Year-to-Date

Today’s Trading

Previous close34.17
Today’s open34.26
Day’s range34.24 - 35.74
Volume1,345,473
Average volume (3 months)2,122,234
Market cap$3.6B
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)-115.91%
Earnings growth (this year)-14.08%
Earnings growth (next 5 years)--
Revenue growth (last year)-89.52%
P/E ratioNM
Price/Sales25,730.20
Price/Book11.53

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+1.12+2.47%
ASPXAuspex Pharmaceutica...+0.06+0.06%
WXWuxi Pharmatech Caym...+2.01+4.66%
NBIXNeurocrine Bioscienc...+1.42+4.17%
Data as of 4:03pm ET, 05/01/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$120.0K
Annual profit (last year)-$92.5M
Net profit margin-77,062.50%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Chief Business Officer &
Executive VP
Stephen R. Davis
Chief Medical Officer &
Executive VP-Development
Roger M. Mills
Corporate headquarters
San Diego, California

Forecasts